Long-term Results after Percutaneous Myotomies and Enriched Fat Grafting for Congenital Muscular Torticollis Treatment.
Monreal J.
Retrospective Study with a reported sample of 24, published in Aesthetic Plast Surg (2025) — summary generated from the PubMed abstract.
Early human evidence such as case series or small samples is exploring possible benefits.
- Level A · Stronger Clinical Evidence
- Level B · Emerging clinical evidence with positive signals
- Level C · Early human research exploring benefits
- Level D · Scientific groundwork from lab and animal studies
- Emerging · Emerging topic under active research
This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.
- Study type
- Retrospective Study
- Journal
- Aesthetic Plast Surg (2025)
- Country
- United States
- Reported sample size
- 24
- Source database
- PubMed
- PMID
- 40461842
- DOI
- 10.1007/s00266-025-04944-3
Abstract (original English)
Objective In 2017, the author first published two clinical cases demonstrating the initial safety and efficacy of a new treatment for congenital muscular torticollis in adults based on percutaneous myotomies and simultaneous fat grafting. This article aims to update the outcomes of this technique by retrospectively analyzing a total of 24 patients. Materials and methods The outcomes of 24 patients with congenital muscular torticollis, with a mean age of 25 years and a minimum follow-up of 24 months, were retrospectively analyzed. Four patients were treated using percutaneous myotomies and enriched fat grafting using an enzymatical isolation protocol for obtaining stromal vascular fraction. The remaining 20 patients were treated with percutaneous myotomies and enriched fat grafting using a mechanical isolation protocol. The study assessed aesthetic and functional improvement using a modified Lee scoring system. Results At 24-month post-treatment, functional and aesthetic improvement was excellent or good in 83.33%, with no relapses, complications, or unwanted side effects. Postoperative MRI controls also showed absence of abnormal muscular architecture. Conclusions The use of percutaneous myotomies and enriched fat grafting is an effective and safe option for treating patients with congenital muscular torticollis of any age. Larger series of patients and a longer follow-up are n
What this study does not prove
- • This study does not prove SVF is an approved treatment or a replacement for standard care.
- • Without an adequate control group, treatment effects cannot be separated from other factors.
Evidence level
Early human evidence such as case series or small samples is exploring possible benefits.
How we grade evidenceBrowse all related research
Filter the research library by this study's title keywords, author, or publication year.